VANDA PHARMACEUTICALS INC's ticker is VNDA and the CUSIP is 921659108. A total of 189 filers reported holding VANDA PHARMACEUTICALS INC in Q4 2022. The put-call ratio across all filers is 2.96 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $264,125 | +79.5% | 61,140 | +173.9% | 0.01% | +66.7% |
| Q2 2023 | $147,109 | +23.5% | 22,323 | +27.2% | 0.01% | +20.0% |
| Q1 2023 | $119,137 | -57.8% | 17,546 | -54.1% | 0.01% | -70.6% |
| Q4 2022 | $282,195 | -18.4% | 38,186 | +20.4% | 0.02% | +30.8% |
| Q2 2022 | $346,000 | +54.5% | 31,720 | +122.1% | 0.01% | +30.0% |
| Q4 2021 | $224,000 | -31.1% | 14,280 | -34.1% | 0.01% | -37.5% |
| Q1 2021 | $325,000 | +9.4% | 21,670 | -29.5% | 0.02% | +14.3% |
| Q3 2020 | $297,000 | +118.4% | 30,723 | +158.4% | 0.01% | +100.0% |
| Q2 2020 | $136,000 | -58.4% | 11,890 | -51.7% | 0.01% | -58.8% |
| Q3 2019 | $327,000 | -1.8% | 24,609 | +4.2% | 0.02% | -5.6% |
| Q2 2019 | $333,000 | – | 23,610 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Palo Alto Investors LP | 2,491,200 | $27,154,000 | 2.37% |
| Profit Investment Management, LLC | 281,890 | $3,071,000 | 2.26% |
| Sio Capital Management, LLC | 488,965 | $5,330,000 | 2.00% |
| Zebra Capital Management LLC | 14,766 | $161,000 | 0.47% |
| Prairiewood Capital, LLC | 50,165 | $547,000 | 0.43% |
| TANG CAPITAL MANAGEMENT LLC | 256,696 | $2,798,000 | 0.42% |
| HUSSMAN STRATEGIC ADVISORS, INC. | 156,000 | $1,700,000 | 0.29% |
| GLOBEFLEX CAPITAL L P | 100,843 | $1,099,000 | 0.27% |
| Epoch Investment Partners, Inc. | 2,757,646 | $30,059,000 | 0.18% |
| EMC Capital Management | 16,185 | $176,000 | 0.15% |